14. 慢性炎症性脱髄性多発神経炎／多巣性運動ニューロパチー Chronic inflammatory demyelinating polyneuropathy Clinical trials / Disease details

臨床試験数 : 175 / 薬物数 : 161 - (DrugBank : 41) / 標的遺伝子数 : 13 - 標的パスウェイ数 : 24

18 trials found

diseases per page:

Showing 1 to 10 of 18 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04589299 (ClinicalTrials.gov)	June 4, 2020	9/9/2020	Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)	Randomized, Parallel Study of Subcutaneous Versus Intravenous Immunoglobulinin Treatment-naïve Patie ...	CIDP - Chronic Inflammatory Demyelinating Polyneuropathy	Biological: Immunoglobulin	University of Aarhus	Rigshospitalet, Denmark;Aarhus University Hospital;Odense University Hospital;Aalborg University Hos ...	Recruiting	18 Years	N/A	All	60	Phase 4	Denmark
2	EUCTR2018-003592-34-DK (EUCTR)	02/08/2019	14/03/2019	Subcutaneous versus intravenous administration of immunoglobulin in newly diagnosed patients with ch ...	Subcutaneous immunoglobulin in de-novo CIDP(Randomized, parallel study of subcutaneous versus intrav ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 21.1;Level: PT;Classificati ...	Trade Name: Hizentra Product Name: Hizentra INN or Proposed INN: Human Immunoglobulin G Other descripti ...	Aarhus University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	60	Phase 4	Denmark
3	EUCTR2017-002511-34-GB (EUCTR)	01/04/2019	08/11/2019	Initial treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) - combined immunoglobu ...	Intravenous immunoglobulinand intravenous methylprednisolone as optimal induction treatment in CIDP ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 21.1;Level: PT;Classificati ...	Trade Name: methylprednisolone Product Name: methylprednisolone Trade Name: sodium chloride 0.9% Product ...	Academic Medical Centre, Amsterdam, NL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	96	Phase 3	Netherlands;United Kingdom
4	EUCTR2017-002511-34-NL (EUCTR)	26/09/2018	17/04/2018	Intravenous immunoglobulinand intravenous methylprednisolone as optimal induction treatment in CIDP( ...	Intravenous immunoglobulinand intravenous methylprednisolone as optimal induction treatment in CIDP( ...	Chronic inflammatory demyelinating polyneuropathy (CIDP);Therapeutic area: Diseases [C] - Nervous Sy ...	Trade Name: Methylprednisolone (Solu-Medrol) Product Name: Methylprednisolon (Solu-Medrol) Trade Name: S ...	Academisch Medisch Centrum	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	96	Phase 3	Netherlands
5	EUCTR2015-000828-28-NL (EUCTR)	26/07/2016	30/11/2015	Immunoglobulins given under the skin to treat patients with multifocal motor neuropathy (MMN). To in ...	Titlle: Subcutaneous immunoglobulins with rHuPH20 in multifocal motor neuropathy (MMN) It is an inte ...	Non-inferiority and safety/tolerance of Hyqvia compared to IVIg in 20 MMN patients with at least one ...	Trade Name: Hyqvia Product Name: Hyqvia	UMC Utrecht	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 3	Netherlands
6	EUCTR2012-001995-12-IT (EUCTR)	19/05/2015	13/03/2013	A European, randomised, double-blind, active comparator-controlled, cross-over, efficacy and safety ...	A European, randomised, double-blind, active comparator-controlled, cross-over, efficacy and safety ...	Multifocal motor neuropathy (MMN) MedDRA version: 15.1;Level: PT;Classification code 10065579;Term: ...	Trade Name: KIOVIG Product Name: KIOVIG INN or Proposed INN: HUMAN NORMAL IMMUNOGLOBULIN Other descript ...	LFB BIOTECHNOLOGIES	NULL	Not Recruiting			Female: yes Male: yes	20	Phase 3	France;Spain;United Kingdom;Italy
7	NCT02414490 (ClinicalTrials.gov)	March 2015	13/3/2015	IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements	Intravenous Immunoglobulin(IVIg) Treatment-Related Fluctuations in Chronic Inflammatory Demyelinatin ...	Chronic Inflammatory Demyelinating Polyneuropathy	Drug: Intravenous Immunoglobulin	University of Minnesota	BriovaRx Infusion Services;CSL Behring	Completed	18 Years	85 Years	All	30		United States
8	NCT02372149 (ClinicalTrials.gov)	February 2015	12/2/2015	IVIg for Demyelination in Diabetes Mellitus	Treatment With Gamunex 10% Intravenous Immunoglobulin(IVIg) for Patients With Demyelination and Diab ...	Peripheral Neuropathy;Diabetes Mellitus;Chronic Inflammatory Demyelinating Polyneuropathy	Drug: 10% intravenous immunoglobulin (IVIg);Drug: 0.9% sodium chloride	University of Toronto	University Health Network, Toronto	Recruiting	18 Years	N/A	Both	25	Phase 4	Canada
9	EUCTR2013-005363-52-NL (EUCTR)	10/09/2014	27/03/2014	Intravenous immunoglobulin overtreatment in CIDP	Intravenous immunoglobulinovertreatment in chronic inflammatory demyelinating polyneuropathy (CIDP) ...	Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP);Therapeutic area: Diseases [C] - Ne ...	Trade Name: Sodium Chloride 0.9% Product Name: Sodium Chloride 0.9% Product Code: RVG 51680	Department of Neurology, Academic Medical Center	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Netherlands
10	NCT01951924 (ClinicalTrials.gov)	December 2013	20/9/2013	LIME Study (LFB IVIg MMN Efficacy Study)	A European, Randomised, Double-blind, Active Comparator Controlled, Cross-over, Efficacy and Safety ...	Motor Neuron Disease	Drug: Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL);Drug:B ...	Laboratoire français de Fractionnement et de Biotechnologies	TFS Trial Form Support	Completed	18 Years	80 Years	Both	23	Phase 3	France;Italy;Spain;United Kingdom

First Previous1 2Next Last